Delivery Order SPE2DB22D2214-SPE2DB25FS5ZU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a contract ceiling value of $2,603.50. This delivery order represents a firm fixed-price procurement with an ultimate completion date of August 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Azithromycin 250 mg tablets in packages of six units. This contract, valued at $6,924.89, represents a firm fixed-price delivery order with an ultimate completion date of May 5, 2025. The award was made through open competition with no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $4,826.00 and an ultimate completion date of July 24, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor at its Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's existing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $6,311.42. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $73,152.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,051.00. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- The Defense Logistics Agency awarded a $10,248.00 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and no set-aside designation was used in the award. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $3,057 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside delivery order supporting federal medical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS5ZUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This contract, valued at $6,100.26, represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order for Azithromycin, a commonly used antibiotic, exemplifies the company's role in fulfilling routine pharmaceutical procurement needs for federal medical supply chains supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 7/31/25 |